SPI
18.551,09
PKT
+155,85
PKT
+0,85
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.10.09 | ABB (Asea Brown Boveri) sell | Société Générale Group S.A. (SG) | |
| 19.10.09 | Kühne + Nagel International kaufen | Euro am Sonntag | |
| 20.10.09 | Julius Bär outperform | Credit Suisse Group | |
| 15.10.09 | Roche kaufen | Hamburger Sparkasse AG (Haspa) | |
| 15.10.09 | Roche akkumulieren | Independent Research GmbH | |
| 14.10.09 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 15.10.09 | Kühne + Nagel International sell | Société Générale Group S.A. (SG) | |
| 14.10.09 | Ypsomed | Zürcher Kantonalbank AG | |
| 14.10.09 | UBS buy | Société Générale Group S.A. (SG) | |
| 14.10.09 | Novartis buy | Helvea | |
| 12.10.09 | Zurich Insurance outperform | Credit Suisse Group | |
| 12.10.09 | Novartis outperform | Cowen and Company, LLC | |
| 12.10.09 | Novartis outperform | Cowen and Company, LLC | |
| 09.10.09 | Novartis buy | Citigroup Corp. | |
| 08.10.09 | Sika | Zürcher Kantonalbank AG | |
| 08.10.09 | Arbonia | Zürcher Kantonalbank AG | |
| 07.10.09 | Novartis kaufen | SEB AG | |
| 02.10.09 | Clariant spekulativ kaufen | Der Aktionärsbrief | |
| 01.10.09 | INFICON buy | UBS AG | |
| 30.09.09 | Novartis buy | Citigroup Corp. | |
| 30.09.09 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.10.09 | Nestlé aufstocken | Oldenburgische LB | |
| 24.09.09 | Novartis | Focus Money | |
| 23.09.09 | UBS buy | Société Générale Group S.A. (SG) | |
| 23.09.09 | Sankt Galler Kantonalbank (N) | Zürcher Kantonalbank AG | |
| 18.09.09 | Swiss Life buy | Deutsche Bank AG | |
| 17.09.09 | ABB (Asea Brown Boveri) hold | Deutsche Bank AG | |
| 15.09.09 | Novartis buy | Jefferies & Company Inc. | |
| 15.09.09 | UBS buy | Société Générale Group S.A. (SG) | |
| 15.09.09 | Roche kaufen | Independent Research GmbH | |
| 14.09.09 | ABB (Asea Brown Boveri) sell | Société Générale Group S.A. (SG) | |
| 11.09.09 | Kühne + Nagel International sell | Société Générale Group S.A. (SG) | |
| 11.09.09 | Kühne + Nagel International | boerse.de-Aktienbrief | |
| 10.09.09 | Novartis outperform | Exane-BNP Paribas SA | |
| 10.09.09 | Zurich Insurance neutral | JP Morgan Chase & Co. | |
| 09.09.09 | UBS neutral | JP Morgan Chase & Co. | |
| 09.09.09 | ams-OSRAM übergewichten | Zürcher Kantonalbank AG | |
| 09.09.09 | Novartis overweight | JP Morgan Chase & Co. | |
| 08.09.09 | Zurich Insurance hold | Jefferies & Company Inc. | |
| 08.09.09 | Novartis buy | Goldman Sachs Group Inc. |